These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26718015)

  • 1. Charge regulation phenomenon predicted from the modeling of polypeptide electrophoretic mobilities as a relevant mechanism of amyloid-beta peptide oligomerization.
    Deiber JA; Peirotti MB; Piaggio MV
    Electrophoresis; 2016 Mar; 37(5-6):711-8. PubMed ID: 26718015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global properties and propensity to dimerization of the amyloid-beta (12-28) peptide fragment through the modeling of its monomer and dimer diffusion coefficients and electrophoretic mobilities.
    Deiber JA; Peirotti MB; Piaggio MV
    Electrophoresis; 2015 Mar; 36(5):805-12. PubMed ID: 25403948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of electrokinetic and hydrodynamic global properties of relevant amyloid-beta peptides through the modeling of their effective electrophoretic mobilities and analysis of their propensities to aggregation.
    Deiber JA; Piaggio MV; Peirotti MB
    J Sep Sci; 2014 Sep; 37(18):2618-24. PubMed ID: 24975363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved capillary electrophoresis method for in vitro monitoring of the challenging early steps of Aβ1-42 peptide oligomerization: application to anti-Alzheimer's drug discovery.
    Brinet D; Kaffy J; Oukacine F; Glumm S; Ongeri S; Taverna M
    Electrophoresis; 2014 Dec; 35(23):3302-9. PubMed ID: 25219962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
    Benseny-Cases N; Klementieva O; Cladera J
    Subcell Biochem; 2012; 65():53-74. PubMed ID: 23224999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global chain properties of an all l-α-eicosapeptide with a secondary α-helix and its all retro d-inverso-α-eicosapeptide estimated through the modeling of their CZE-determined electrophoretic mobilities.
    Deiber JA; Piaggio MV; Peirotti MB
    Electrophoresis; 2014 Mar; 35(5):755-61. PubMed ID: 24293200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unravelling the mechanism of amyloid-β peptide oligomerization and fibrillation at chiral interfaces.
    Gong S; Liu J; Tian M; Wang K; Cai S; Wang W; Shen L
    Chem Commun (Camb); 2019 Nov; 55(91):13725-13728. PubMed ID: 31660558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between gold nanoparticles and amyloid β25-35 peptide.
    Peng J; Weng J; Ren L; Sun LP
    IET Nanobiotechnol; 2014 Dec; 8(4):295-303. PubMed ID: 25429511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-barrel Oligomers as Common Intermediates of Peptides Self-Assembling into Cross-β Aggregates.
    Sun Y; Ge X; Xing Y; Wang B; Ding F
    Sci Rep; 2018 Jul; 8(1):10353. PubMed ID: 29985420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of acidity constants and prediction of electrophoretic separation of amyloid beta peptides.
    Peró-Gascón R; Benavente F; Barbosa J; Sanz-Nebot V
    J Chromatogr A; 2017 Jul; 1508():148-157. PubMed ID: 28619586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-amyloidogenic property of human gastrokine 1.
    Altieri F; Di Stadio CS; Severino V; Sandomenico A; Minopoli G; Miselli G; Di Maro A; Ruvo M; Chambery A; Quagliariello V; Masullo M; Rippa E; Arcari P
    Biochimie; 2014 Nov; 106():91-100. PubMed ID: 25139219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro monitoring of amyloid β-peptide oligomerization by Electrospray differential mobility analysis: An alternative tool to evaluate Alzheimer's disease drug candidates.
    Brinet D; Gaie-Levrel F; Delatour V; Kaffy J; Ongeri S; Taverna M
    Talanta; 2017 Apr; 165():84-91. PubMed ID: 28153323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary characterization of a novel peptide-Fc-fusion construct for targeting amyloid deposits.
    Foster JS; Koul-Tiwari R; Williams A; Martin EB; Richey T; Stuckey A; Macy S; Kennel SJ; Wall JS
    Amyloid; 2017 Mar; 24(sup1):26-27. PubMed ID: 28434354
    [No Abstract]   [Full Text] [Related]  

  • 15. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes.
    Nardo L; Re F; Brioschi S; Cazzaniga E; Orlando A; Minniti S; Lamperti M; Gregori M; Cassina V; Brogioli D; Salerno D; Mantegazza F
    Biochim Biophys Acta; 2016 Apr; 1860(4):746-56. PubMed ID: 26774643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid fibrillation kinetics: insight from atomistic nucleation theory.
    Cabriolu R; Auer S
    J Mol Biol; 2011 Aug; 411(1):275-85. PubMed ID: 21645521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of amyloid: structure, function, and regulation.
    Greenwald J; Riek R
    Structure; 2010 Oct; 18(10):1244-60. PubMed ID: 20947013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of amyloid oligomers toxicity.
    Kayed R; Lasagna-Reeves CA
    J Alzheimers Dis; 2013; 33 Suppl 1():S67-78. PubMed ID: 22531422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.